Smart Money Alert
Emcure Pharmaceuticals Limited
New PositionBlock Deal
EMCUREPharmaceuticalsMarket Cap₹36K Cr
Value
₹101 Cr
Shares
5,56,954
Price
₹1,817
HDFC Life Insurance
Institution
The move
HDFC Life Insurance bought 5,56,954 shares of Emcure Pharmaceuticals for ₹101.20 Cr at ₹1817.00 apiece in a block deal.
About Emcure Pharmaceuticals Limited
Visit stock A global pharmaceutical manufacturer established in 1981, Emcure Pharmaceuticals produces and markets a comprehensive range of drug formulations across multiple therapeutic areas for domestic and international markets. The company operates manufacturing facilities that serve patients globally, focusing on both generic and specialty pharmaceutical products. Emcure's diversified operations and geographic presence establish it as a significant player in the pharmaceutical industry.
About HDFC Life Insurance
Visit investor HDFC Life Insurance Company Limited, institutional investor in Indian equities
Get the next move the moment it happens.
Follow HDFC Life Insurance and Emcure Pharmaceuticals Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Morgan StanleyNew position
Morgan Stanley bought 1,37,590 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1817.00 apiece in a block deal. This transaction occurred on June 25, 2026.
25 Jun 2026
Read more HSBC Mutual FundNew position
HSBC Mutual Fund bought 1,37,590 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1,817.00 apiece in a block deal.
25 Jun 2026
Read more Goldman SachsNew position
Goldman Sachs bought 1,37,590 shares of Emcure Pharmaceuticals Limited for ₹25.00 Cr at ₹1817.00 apiece in a block deal.
25 Jun 2026
Read more BNP ParibasNew position
BNP Paribas bought 137,592 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1817.00 apiece in a block deal.
25 Jun 2026
Read more Axis Mutual FundNew position
Axis Mutual Fund bought 1,37,590 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1817.00 apiece in a block deal.
25 Jun 2026
Read more Gland Pharma Limited
Direction, size, price and stake change for this move, with what it means for the company.
4 Sept 2026. Sign in to see this move
Meesho LimitedNew position
HDFC Life Insurance bought 60 lakh shares of Meesho Limited for ₹123.78 Cr at ₹206.30 apiece in a block deal.
MEESHO3 Sept 2026
Read more Meesho LimitedNew position
HDFC Life Insurance bought 60 lakh shares of Meesho Limited for ₹123.78 Cr at ₹206.30 apiece in a block deal.
MEESHO3 Sept 2026
Read more SBFC Finance LimitedNew position
HDFC Life Insurance bought 73 lakh shares of SBFC Finance for ₹73.73 Cr at ₹101.00 apiece in a bulk deal.
SBFC1 Sept 2026
Read more Lenskart Solutions LimitedNew position
HDFC Life Insurance bought 12,69,838 shares of Lenskart Solutions for ₹80.00 Cr at ₹630.00 apiece in a block deal. This transaction occurred on the same day that Alpha Wave Ventures II was expected to sell a 1.2% stake in Lenskart worth ₹1,313 crore.
LENSKART28 Aug 2026
Read more